Compare
Nature's Sunshine Products Inc vs BridgeBio Pharma, Inc. vs Zai Lab Ltd vs Arrowhead Pharmaceuticals, Inc.
| Latest fiscal year | Nature's Sunshine Products Inc NATR | BridgeBio Pharma, Inc. BBIO | Zai Lab Ltd ZLAB | Arrowhead Pharmaceuticals, Inc. ARWR |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-09-30 |
| Revenue | $480.14M | $502.08M | $457.18M | $450.82M |
| Revenue growth (YoY) | +5.7% | +126.3% | +15.0% | -45.6% |
| Gross margin | 72.4% | n/a | 58.3% (computed) | n/a |
| Operating margin | 5.2% | -104.2% | -50.2% | -156.9% |
| Net margin | 4.3% | -146.0% | -38.4% | -159.1% |
| Net income | $20.45M | -$732.94M | -$175.54M | -$717.13M |
| EPS (Diluted) | $1.06 | -$3.78 | -$0.16 | -$5.11 |
| Operating cash flow | $35.32M | -$445.91M | -$150.79M | -$271.95M |
| Free cash flow | $28.84M | -$447.01M | -$158.89M | -$283.94M |
| Cash & equivalents | $93.89M | $570.12M | $679.57M | n/a |
| Total assets | $261.15M | $936.02M | $1.17B | $1.74B |
| Total liabilities | $99.59M | $3.01B | $456.88M | n/a |
| Shareholders' equity | $161.55M | -$2.09B | $715.50M | $50.50M |
| Return on year-end equity | 12.7% | n/a | -24.5% | n/m |
| Shares outstanding | 17.51M | 194.77M | 1.11B | 141.29M |
Revenue, most recent five fiscal years
| Fiscal year | Nature's Sunshine Products Inc | BridgeBio Pharma, Inc. | Zai Lab Ltd | Arrowhead Pharmaceuticals, Inc. |
|---|---|---|---|---|
| Latest | $480.14M Ended 2025-12-31 | $502.08M Ended 2025-12-31 | $457.18M Ended 2025-12-31 | $450.82M Ended 2026-09-30 |
| 1 year earlier | $454.36M Ended 2024-12-31 | $221.90M Ended 2024-12-31 | $397.61M Ended 2024-12-31 | $829.45M Ended 2025-09-30 |
| 2 years earlier | $445.32M Ended 2023-12-31 | $9.30M Ended 2023-12-31 | $266.72M Ended 2023-12-31 | $3.55M Ended 2024-09-30 |
| 3 years earlier | $421.91M Ended 2022-12-31 | $77.65M Ended 2022-12-31 | $212.67M Ended 2022-12-31 | $240.74M Ended 2023-09-30 |
| 4 years earlier | $444.08M Ended 2021-12-31 | $69.72M Ended 2021-12-31 | $144.10M Ended 2021-12-31 | $243.23M Ended 2022-09-30 |